Hibiscus sabdariffa / Casp3 Cancer Research Results

Hibiscus sabdariffa — commonly known as roselle, is an edible medicinal plant whose calyces and leaves contain anthocyanins, polyphenols, flavonoids, phenolic acids, and organic acids. It is classified as a botanical food/nutraceutical and plant-extract modality rather than a defined anticancer drug. Standard abbreviations include HS and H. sabdariffa. The calyx is the predominant food and beverage source, whereas several anticancer studies have used leaf extracts, anthocyanin-rich fractions, or polyphenol-enriched preparations that are not compositionally equivalent to ordinary hibiscus tea. Important constituents include delphinidin-3-sambubioside, cyanidin-3-sambubioside, protocatechuic acid, and other polyphenols.

-Calyx — the thick, fleshy red structure surrounding the base of the flower and later the seed capsule. This is the main material used for hibiscus tea, beverages, extracts, and most commercial supplements. It is especially rich in anthocyanins, organic acids, and polyphenols.
-Epicalyx — a ring of smaller bract-like structures immediately outside the calyx. These are often harvested together with the calyx and may be included in dried commercial “hibiscus flower” material.

Primary mechanisms (ranked):

1. Induction of intrinsic and extrinsic apoptosis through ↑ Bax/Bcl-2 ratio, mitochondrial dysfunction/cytochrome-c signaling, caspase activation, and p53/p38 MAPK/Fas/FasL pathways.
2. Suppression of tumor-cell proliferation and survival through cell-cycle disruption and modulation of RB, p53, MAPK, Akt and related survival signaling.
3. Mitochondrial oxidative stress with ↑ ROS and ↓ mitochondrial membrane potential in susceptible cancer cells; this contributes to apoptosis and can enhance chemotherapy-induced cytotoxicity.
4. Autophagy modulation, including autophagic cell death in some melanoma models, with involvement of PI3K class III/Beclin-1/LC3 and Akt/mTOR signaling.
5. Estrogen receptor α modulation in ER-positive breast cancer, including altered ERα localization/activity; this mechanism is subtype-dependent rather than a universal Hibiscus effect.
6. Suppression of migration/invasion and other metastatic phenotypes in selected breast, prostate, and other tumor models.
7. Anti-inflammatory and antioxidant modulation, including attenuation of pro-inflammatory and oxidative signaling; these effects are more established in non-cancer experimental and human contexts than as direct tumor-killing mechanisms.

Bioavailability / PK relevance: Hibiscus anthocyanins are orally absorbed but have low systemic bioavailability and are rapidly metabolized and eliminated. Human pharmacokinetic studies demonstrate circulating anthocyanin-derived compounds after oral Hibiscus extract, but exposure to intact parent anthocyanins is substantially lower than concentrations commonly used in mechanistic cell-culture studies. Extract composition, plant part, cultivar, processing, and extraction method materially affect exposure.

In-vitro vs systemic exposure relevance: Many anticancer experiments use approximately hundreds of µg/mL to mg/mL of crude or polyphenol-enriched extract, or high-µM to millimolar concentrations of individual phenolic compounds. These concentrations generally exceed plausible circulating concentrations following ordinary dietary Hibiscus consumption. Direct translation of in-vitro anticancer potency to oral tea or supplement use is therefore poor. Local gastrointestinal exposure may be considerably higher than systemic exposure.

Clinical evidence status: Cancer evidence is predominantly preclinical, consisting of cell-culture studies and limited animal models; there is no established human anticancer efficacy and no validated Hibiscus anticancer dosing regimen. Human RCT evidence is considerably stronger for blood-pressure reduction and some cardiometabolic effects than for cancer treatment. Hibiscus should therefore be categorized as preclinical for anticancer therapy, not as an established cancer adjunct. Oral Hibiscus preparations are generally well tolerated in short-term human studies, but clinically relevant hypotensive and glucose-lowering effects can occur, creating potential additive effects with antihypertensive or antidiabetic therapy.

Hibiscus sabdariffa Cancer-Relevant Mechanisms

P: 0–30 min     R: 30 min–3 hr     G: >3 hr